The momentum around psychedelic research is transforming the landscape of mental health treatment, driven by their potential to address conditions like depression, PTSD, and substance use disorders. Compounds such as psilocybin and MDMA are showing promise by disrupting entrenched thought patterns and enhancing the effectiveness of psychotherapy.